Suppr超能文献

经桡动脉 Szabo 技术用于介入治疗开口病变。

Transradial Szabo technique for intervention of ostial lesions.

机构信息

Beth Israel Medical Center, New York, New York 10013, USA.

出版信息

J Interv Cardiol. 2012 Oct;25(5):447-51. doi: 10.1111/j.1540-8183.2012.00750.x. Epub 2012 Jun 4.

Abstract

OBJECTIVES

The aim of our study is to assess the feasibility and safety of transradial intervention (TRI) of coronary ostial lesions using the Szabo technique.

BACKGROUND

When performing TRI of coronary ostial lesions, precise stent positioning is of paramount importance. TRI has experienced increasing popularity in the U.S.; however, utilization of the Szabo technique has not been systematically evaluated in this setting. We report the results of ostial stent deployment using the Szabo technique for 2 experienced TRI operators and centers.

METHODS

This was a retrospective analysis of 40 consecutive patients who underwent PCI from April 2009 to September 2011. All patients who underwent PCI via the transradial route with the Szabo technique for ostial lesions performed by experienced transradial operators (>200 cases/yr) were included.

RESULTS

In our study of 40 patients with 41 coronary ostial lesions, overall procedural success rate was 100%. Stent dislodgement was seen in 1 patient. Clinical follow up was 100%, with a mean duration of 292.7±200 days. Target lesion revascularization (TLR) was seen in 2 patients (5%). One patient had an episode of transient ischemic attack (TIA) at 33 days after PCI; another experienced subacute stent thrombosis at 81 days while on dual antiplatelet therapy. MACE was 7.5% overall.

CONCLUSION

In our study, treatment of coronary ostial lesions with the Szabo technique via TRI is associated with a high procedural success rate and a low MACE of 7.5%.

摘要

目的

本研究旨在评估 Szabo 技术经桡动脉入路(TRI)治疗冠状动脉开口病变的可行性和安全性。

背景

在进行冠状动脉开口病变的 TRI 时,精确的支架定位至关重要。TRI 在美国越来越受欢迎,但在这种情况下,Szabo 技术的应用尚未得到系统评估。我们报告了 2 名经验丰富的 TRI 操作者和中心使用 Szabo 技术进行开口支架置入的结果。

方法

这是一项回顾性分析,纳入了 2009 年 4 月至 2011 年 9 月期间接受经皮冠状动脉介入治疗(PCI)的 40 例连续患者。所有接受经桡动脉途径 Szabo 技术治疗的患者均包括在内,这些患者均为经验丰富的经桡动脉操作者(>200 例/年)治疗的开口病变。

结果

在我们的研究中,40 例患者共 41 处冠状动脉开口病变,整体手术成功率为 100%。1 例患者发生支架移位。100%的患者进行了临床随访,平均随访时间为 292.7±200 天。2 例患者(5%)发生靶病变血运重建(TLR)。1 例患者在 PCI 后 33 天发生短暂性脑缺血发作(TIA);另 1 例患者在双联抗血小板治疗 81 天时发生亚急性支架内血栓形成。主要不良心血管事件(MACE)的总发生率为 7.5%。

结论

在我们的研究中,Szabo 技术经 TRI 治疗冠状动脉开口病变的成功率高,MACE 发生率低(7.5%)。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验